Left ventricular unloading with Impella versus IABP in patients on VA-ECMO for cardiogenic shock

نویسندگان

چکیده

Abstract Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) use for circulatory support in shock is limited by increased left ventricular afterload. Impella and intra-aortic balloon pump (IABP) can be used conjunction with VA-ECMO to help unload the ventricle. Data comparing two strategies are limited. Purpose We performed a systematic review meta-analysis of published data compare outcomes patients supported versus IABP. Methods conducted search Medline, Embase, Cochrane databases identify studies IABP on VA-ECMO. The primary outcome interest was all-cause mortality (in-hospital or 30-day). Secondary included transition destination therapy assist device (LVAD) transplant, stroke, need continuous renal replacement (CRRT), bleeding, hemolysis. Risk ratios (RR) 95% confidence interval heterogeneity statistic I2 were reported each outcome. Results Six observational total 629 analysis. Of these, 205 (33%) 424 (67%) respectively, addition All six No difference observed between (RR 1.02 [0.74–1.40], I2=74%). Similar rates LVAD transplant 0.75 [0.45–1.27], I2=0%), stroke 1.50 [0.80–2.83], CRRT 1.04 [0.82–1.32], I2=0%). However, associated higher risk bleeding 1.91 [1.28–2.86], I2=68%) hemolysis 4.61 [1.24–17.17], I2=66%) as compared Conclusion In requiring VA-ECMO, concurrent had similar mortality, LVAD/transplant, CRRT. Randomized trials needed optimal strategy unloading cardiogenic Funding Acknowledgement Type funding sources: None.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Postcardiotomy VA-ECMO for refractory cardiogenic shock

Postcardiotomy cardiogenic shock (PCCS) is a rare but catastrophic syndrome that can occur following separation from cardiopulmonary bypass or at any time during the immediate postoperative course. The management of PCCS varies between clinicians, institutions and countries. The available evidence to guide this practice is limited. In their systematic review and meta-analysis, Khorsandi and col...

متن کامل

Cardiogenic shock: From ECMO to Impella and beyond.

For patients in cardiogenic shock, several devices can serve as a "bridge," ie, provide circulatory support and allow the patient to live long enough to recover or to receive a heart transplant or a long-term device. Options include an intra-aortic balloon pump, TandemHeart, Impella, extracorporeal membrane oxygenation (ECMO), and CentriMag. Which device to use depends on individual patient nee...

متن کامل

Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery

BACKGROUND Mechanical circulatory support is a common practice nowadays in the management of patients after cardiogenic shock due to myocardial infarction. The single or combined use of one or more devices for mechanical support depends not only on the advantage or disadvantage of these devices but also on the timing of use of these devices before the development of multi organ failure. In our ...

متن کامل

The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience

BACKGROUND The treatment of cardiogenic shock with percutaneous mechanical circulatory support (MCS) is attractive: however, at present it is not clear which is the best strategy, as no survival benefit has been demonstrated for any device as single therapy. Aim of this study is to describe the role of percutaneous Impella in a comprehensive MCS program. METHODS Observational study on 22 pati...

متن کامل

[Initial experience with the Impella left ventricular assist device for postcardiotomy cardiogenic shock and unprotected left coronary artery angioplasty in patients with a low left ventricular ejection fraction].

Low-output syndrome is one of the leading causes of death following open-heart surgery or high-risk angioplasty. Ventricular assist devices have been used to treat patients who suffer from postoperative cardiogenic shock despite use of an intraaortic balloon pump and maximum inotropic support. The Impella pump (Impella Cardiosystems AG, Aachen, Germany) is a newly introduced left ventricular as...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal

سال: 2022

ISSN: ['2634-3916']

DOI: https://doi.org/10.1093/eurheartj/ehac544.1106